ANTIMICROBIAL AGENTS CHEMOTHERAPY, Sept. 2003, p. 2875â€“2881                                                                   Vol. 47,  9
0066-4804/03/$08.00â«¹0 DOI: 10.1128/AAC.47.9.2875â€“2881.2003
Copyright Â© 2003, American Society Microbiology. Rights Reserved.



      Intracellular Expression Peptide Fusions Demonstration                        Protein Essentiality Bacteria
            R. Edward Benson, Elizabeth B. Gottlin, Dale J. Christensen, Paul T. Hamilton*
                                               Karo Bio USA, , Durham, NC 27703
                       Received 16 December 2002/Returned modification 31 March 2003/Accepted 6 June 2003

            â€œprotein knockoutâ€? technique used identify essential proteins bacteria.           technique uses phage display select peptides bind specifically purified target proteins. peptides
          expressed intracellularly cause inhibition growth protein essential. study,
          peptides specifically bind seven essential proteins identified phage display           expressed fusions glutathione S-transferase Escherichia coli. Expression peptide fusions directed
          E. coli DnaN, LpxA, RpoD, ProRS, SecA, GyrA, Era dramatically inhibited cell growth.           conditions, fusion randomized peptide sequence did inhibit cell growth. growth-
          inhibited cells, inhibition relieved concurrent overexpression relevant target protein           coexpression irrelevant protein, indicating growth inhibition specific interaction           expressed peptide target. protein knockout technique used assess essentiality           genes unknown function emerging sequencing microbial genomes. technique           used validate proteins drug targets, corresponding peptides screening tools, discovery           new antimicrobial agents.


   Despite success antimicrobial agents, infectious dis-              prior knowledge protein function. Proteins expressed,
ease second leading cause death worldwide (14).                purified, used phage display isolate peptides bind large increased resistance pathogens            specifically  peptides expressed intracel- variety antimicrobials accelerating trend.              lularly glutathione S-transferase (GST) fusions, evident dynamic resilient nature microbial life,             effect growth monitored. protein essential, cell
coupled profligate use antibiotics, selected                 growth inhibited.
drug-resistant microbes wide spectrum pathogenic                    protein knockout strategy builds observations
organisms. clear urgent need novel antibi-                reported previously. shown otics help combat problem (8, 10, 30).                               peptides selected phage display directed functional
   antibiotics use today directed             sites target proteins (reviewed reference 26). ex-
small number bacterial targets, shortage po-               tension previous work isolating peptide inhibitor tential targets. Analyses bacterial genomes allowed                  prolyl-tRNA synthetase (ProRS) (24), Tao et al. showed estimates â€œminimal genome setâ€? genes essential                 intracellular expression peptide fused GST viability. comparison genomes Haemophilus influ-                 slow bacterial growth rescue mice lethal
enzae Mycoplasma genitalium identified 256 genes consid-                 dose virulent Escherichia coli. (46). Specific inhibition ered necessary sufficient cell viability, study           ProRS cell demonstrated decrease frequency indispensable genes Bacillus subtilis                intracellular pool charged tRNAPro. Walker et al. (47) ex-
genome arrived 250 450 essential genes (25, 32).                  pressed 20,000 peptides E. coli 21 range genes constitute number potential                growth inhibitory;  targets peptides
targets antimicrobial drug discovery, number far larger                unknown. study showed importance using dozen sites action currently existing              peptides fused proteins amino acid motifs improve
antibiotics. Genome-sequencing efforts increased po-                stability. Blum et al. (1) induced expression library tential development new classes antibiotics directed
                                                                             peptides fused thioredoxin selected cells possessing novel targets (15, 39, 42). potential targets
                                                                             ThyAâ«º phenotype (trimethoprim resistance thymine
revealed sequencing unknown function,                                                                              requirement growth). discovered peptides inhib- known function used drug
                                                                             ited cell growth phenotype sup-
targets. pressing need technologies                                                                              pressed overexpression ThyA protein. Peptide expression
validate invalidate targets drug discovery showing
                                                                             used knock protein function dissect essential microbial survival.
                                                                             signal transduction pathways eukaryotic cells (5, 7, 9, 13, 17,
   â€œprotein knockoutâ€? method demon-
                                                                             18, 41).
strating essentiality bacterial proteins requires                                                                                 study, showed protein-specific peptides                                                                              selected vitro used assess essentiality
  * Corresponding author. Mailing address: Karo Bio USA, , 4222
                                                                             wide variety proteins bacteria. demonstrated Emperor Blvd., Suite 560, Durham, NC 27703. Phone: (919) 474-8888            method proteins known essential E. coli, includ-
ext. 13. Fax: (919) 474-0103. E-mail: paul.hamilton@karobio.com.             ing involved nearly basic cellular process: DNA

                                                                      2875
 2876       BENSON ET AL.                                                                                                     ANTIMICROB. AGENTS CHEMOTHER.


replication (DnaN), lipid biosynthesis (LpxA), transcription                          Phage display. Immulon 4 96 plates (Thermo Labsystems, Franklin,
initiation (RpoD â?´70), translation (ProRS), protein secre-                        Mass.) coated streptavidin (1 â?®g  0.1 M sodium bicarbonate
                                                                                     blocked 1  bovine serum albumin. Biotinylated protein (4 pmol 
tion (SecA), DNA supercoiling (GyrA),                             diluted TBST (10 mM Tris-HCl [pH 8.0], 150 mM NaCl, 0.05  Tween 20)
essential protein unknown function (Era). assessed                        allowed bind plate 1 h. plates washed TBST, specificity intracellular protein-peptide interaction                     phage 20 recombinant M13 libraries (total complexity 2 â«» 1010) performing protein overexpression rescue experiments.                             allowed bind 1 h. plates washed  bound phage
                                                                                     eluted, amplified, used round phage selection 
                                                                                     scribed previously (44). rounds selection, phage pools                         MATERIALS METHODS                                        plated single plaques purified DNA sequence individual
   Bacterial strains media. work, base medium 2â«»YT               isolates determined. Peptides synthesized include 12- 15-
supplemented appropriate antibiotics chloramphenicol  30            amino-acid sequence displayed phage followed short linker â?®g/ml), spectinomycin  100 â?®g/ml), kanamycin  30 â?®g/ml). E. coli        biotin C terminus allow labeling analysis peptide binding. Isola-
DH5â?£Pro purchased BD Biosciences/Clontech (Palo Alto, Calif.). E.           tion use ProRS-specific phage described previously (24, 46);
coli BL21(DE3) cells electrocompetent JS5 cells purchased Bio-         peptide Pro-3 publications referred peptide 72 work.
Rad (Hercules, Calif.). electrocompetent cells, needed, pre-            Cloning vectors intracellular expression peptide fusion protein.
pared follows. cells grown overnight 37Â°C 20 ml             commercially available plasmids altered cloning purposes.
appropriate medium, diluted 1 liter, grown optical density 0.5          Vector peptide expression. Plasmid pPROTet.E332-lacZ modified wavelength 600 nm. cells pelleted washed ice-cold sterile    cloning peptide sequences GST fusions introducing cassette
10  glycerol volumes 1 liter, 500 ml, 250 ml, 125 ml, finally 5 ml.   SalI NheI sites peptide sequence cloning replacing lacZ frozen â«º80Â°C.                                                                gene gst gene. Oligonucleotides ProtetSal/Nhe5 ProtetSal/Nhe3
   DNA manipulations synthesis oligonucleotide peptides. PCR          annealed 95Â°C 2 min 1â«» SURE/CUT buffer B (Roche) carried using Expand High-Fidelity PCR (Roche, Indianapolis,          allowed cool room temperature. DNA cut HindIII Ind.) conjunction Techne Genius thermal cycler (Techne, Princeton,       KpnI ligated pPROTet.E332-lacZ vector previously cut HindIII
N.J.). Restriction enzymes T4 DNA ligase New England Biolabs           KpnI. Transformants screened presence NheI site, (NEB; Beverly, Mass.). DNA purified using kits purchased Qiagen             DNA sequences plasmids confirmed. gst gene amplified (Valencia, Calif.). Electroporation carried 0.1-cm cuvettes Bio-     PCR pGEX2T (Amersham BioSciences, Piscataway, N.J.) primers
Rad E. coli Pulser device 1.8 kV. DNA sequence analysis carried        tGST5 tGST3. set primers introduced linker region Sequetech Corp. (Mountain View, Calif.). Oligonucleotides synthesized        multiple-cloning site gst. PCR product cut HindIII PstI Midland Certified Reagent ,  (Midland, Tex.). Peptides synthe-       ligated modified pPROTet.E332-lacZ vector cut sized AnaSpec,  (San Jose, Calif.).                                           enzymes. Transformants screened presence introduced BamHI
   Oligonucleotides. oligonucleotides annealed used make           site, plasmids confirmed sequence analysis. resulting plasmid cassette introduce SalI NheI sites pPROTet.E332-lacZ (BD Bio-            pKBU-Tet/GST (Fig. 1A).
sciences/Clontech; . ProtetSal/Nhe5 ProtetSal/Nhe3,              (ii) Vector target protein expression. Plasmid pProLar.A222 (Clontech)
respectively (5â¬˜-GAGAAAGGTACCCATGTCGACAGGTTAGGCTAGCAC                                modified introducing cassette NdeI, BspHI, SmaI cloning sites
AAGCTTGGATACT 5â¬˜-AGTATCCAAGCTTGTGCTAGCCTAACCTG                                   KpnI PacI sites create pKBU-Pro-Lar (Fig. 1B).
TCGACATGGGTACCTTTCTC). oligonuclcotides annealed                           Construction plasmids peptide expression. peptide expression
used make cassette introduce new multicloning site pPROLar.A222.      plasmid  exception ProRS peptide-encoding plasmid) pKBU-Pro-Lar5 pKBU-Pro-Lar3, respectively (5â¬˜-CATATGCTC                 specific pair 5â¬˜-phosphorylated oligonucleotides insertion ATGAGGTAATAACCCGGGCGTTAAT 5â¬˜-TAACGCCCGGGTTATTA                                   SalI NheI cloning sites pKBU-Tet/GST (Fig. 1A). oligonucleotide
CCTCATGAGCATATGGTAC). PCR primers used clone GST                        resuspended 1 â?®g/â?®l 10 mM Tris-HCl (pH 8.0)â€“1 mM EDTA (TE), hinge) pPROTet.E332 (Hind3-PstI) primers tGST5 tGST3, respec-           9.5 â?®l sense oligonucleotide 9.5 â?®l antisense oligonucleotide
tively (5â¬˜-GATCGATCAAGCTTGGGATCAGGATCCATGTCCCCTATACT                                 mixed 1 â?®l 5M NaCl TE placed heat block 80Â°C. AGGTTATTGG 5â¬˜-GATCGATCCTGCAGCCTCACAGATCCGATTTT                                   30 min, block removed heater allowed cool 30Â°C. GGAGGATGGTCGCC).                                                                     annealed cassette diluted TE 200 â?®l ligated pKBU-
   clone target genes pTYB2AT pTYB4AT  , following          Tet/GST; 2 â?®l ligation mixture transformed 20 â?®l electro-
pairs PCR primers used, set named protein     competent DH5â?£Pro cells. Cells plated medium containing chloram- end gene hybridize (5 â«½ 5â¬˜; 3 â«½ 3â¬˜): LpxA5 (5â¬˜-ATG          phenicol grown overnight 37Â°C. isolates ligation ATCGACATATGATTGATAAATCCGCCTTTGTGC) LpxA3 (5â¬˜-GATC                                picked cultured, insert-positive isolates identified PCR ampli-
GACCCGGGACGAATCAGACCGCGCGTTGAGCG), DnaN5 (5â¬˜-TCGTCA                                  fication primers outside insert region. Positive isolates se-
TCCATATGAAATTTACCGTAGAACGTGAGCA) DnaN3 (5â¬˜-TCGTC                                 quenced oligonucleotide 5â¬˜ProTet confirm correct sequences ATCCCCGGGCAGTCTCATTGGCATGACAACATAA), RpoD5 (5â¬˜-ATGA                                  peptide-coding inserts.
TCGACATATGGAGCAAAACCCGCAGTCACAGC) RpoD3 (5â¬˜-GATC                                    Construction plasmids protein expression. intracellular expression
GACCCGGGATCGTCCAGGAAGCTACGCAGC), Era5 (5â¬˜-GATCGTACC                                  experiments, target genes removed pTYB2AT pTYB4AT
ATGGGAAGCATCGATAAAAGTTACTGCGG) Era3 (5â¬˜-GATCGACC                                 constructs used protein production restriction sites used clone
CGGGAAGATCGTCAACGTAACCGAGACTGCG), GyrA5 (5â¬˜-TCGTCAT                                   flanking sites) recloned compatible sites vector
CCATATGAGCGACCTTGCGAGAGAAATTAC) GyrA3 (5â¬˜-TCGTCA                                 pKBU-Pro-Lar (Fig. 1B). resulting constructs transformed JS5
TCGATATCTTCTTCTTCTGGCTCGTCGTCAACG), SecA5 (5â¬˜-TCGTC                              cells, sequences confirmed, plasmids repurified trans-
ATCCATATGCTAATCAAATTGTTAACTAAAG) SecA3 (5â¬˜-TCGTCA                                formed DH5â?£Pro cells.
TCCCCGGGTTGCAGGCGGCCATGGCACTGCTTG).                                                     Induction peptide fusions. Overnight cultures sequence-confirmed 
   sequencing primer used confirm cloning peptides 5â¬˜ProTet            structs diluted 1:100 (10 â?®l 1 ml) 96 block fresh
(5â¬˜-CATCAGCAGGACGCACTGAC). sequencing primer used confirm                     selective medium addition inducer anhydrotetracycline (BD Bio-
cloning target genes pKBU-Pro-Lar 5â¬˜ProLar (5â¬˜-GTGAGCGCTC                sciences/Clontech) 100 ng/ml. cultures grown 22Â°C shaking,
ACAATTATGATAG).                                                                      optical densities (absorbance 600 nm) read SpectraMax 190
   Cloning target genes protein purification. Genes encoding target pro-      spectrophotometric plate reader (Molecular Devices, Sunnyvale, Calif.) 12, 24,
teins amplified PCR specific oligonucleotides. amplified prod-      36, 48 h.
ucts cloned pTYB2AT pTYB4AT, vectors based TYB2                     Coinduction peptide fusions target proteins. Cells bearing pKBU-Tet-
TYB4 (NEB), respectively, altered include 15-amino-acid vivo biotinyla-      peptide-GST constructs electrocompetent transformed tion signal C terminus purified protein. construct trans-     pKBU-Pro-Lar-target constructs, plated 2â«» YT plus kanamycin, formed BL21(DE3) cells (Stratagene, La Jolla, Calif.) carrying pBirAcm      grown overnight 37Â°C. Isolates picked grown medium chlor-
plasmid (Avidity, Denver, Colo.) encodes biotin ligase. Plasmid DNA         amphenicol, spectinomycin, kanamycin, presence constructs
isolated, inserts confirmed DNA sequencing. Protein pro-         cells confirmed sequencing DNA individual sets duced purified NEB IMPACT method.                                         plasmid-specific primers. Overnight cultures cells bearing plasmids  VOL. 47, 2003                                                                          PROTEIN KNOCKOUT PEPTIDE EXPRESSION                                  2877

                                                                                              TABLE 1. Amino acid sequences peptides described
                                                                                                               report
                                                                                     Peptide                 E. coli
                                                                                                                                         Amino acid sequence
                                                                                     ID                   target

                                                                                      72a                   ProRS                 SREWHFWRDYNPTSR
                                                                                      729                   RpoD                  SRSFSEWREEWLRSR
                                                                                      920                   LpxA                  SSGWMLDPIAGKWSR
                                                                                      1330                  SecA                  SSFSFDGHVWYPVLPAQSR
                                                                                      1337                  DnaN                  SSATRGWHQLDLFSR
                                                                                      1396                  GyrA                  SSGWPQWFPGVGWSR
                                                                                      1706                  Era                   SSEAWRKWLSADFSR
                                                                                      RND                   Control               SREWDRLWHPWLQSR
                                                                                                                                                                                  Peptide 72 peptide Pro-3 references 24 46.




                                                                                     proteins electroblotted polyvinylidene difluoride membranes probed
                                                                                     anti-GST antibody covalently linked alkaline phosphatase (Santa Cruz
                                                                                     Biotechnology, Santa Cruz, Calif.). blots developed WesternBlue
                                                                                     substrate (Promega Corp., Madison, Wis.).


                                                                                                                       RESULTS
                                                                                        Isolation peptides bind specifically essential E. coli
                                                                                     proteins. genes encoding DnaN, LpxA, RpoD, ProRS,
                                                                                     SecA, GyrA, Era essential E. coli (2, 16, 29, 33,
                                                                                     35, 36, 40). genes amplified PCR E. coli
                                                                                     strain K-12 genomic DNA cloned expression vectors,
                                                                                     DNA sequences confirmed, proteins                                                                                      expressed purified. biotinylated target protein                                                                                      immobilized individual wells streptavidin-coated plastic
                                                                                     96 plate. Recombinant M13 phage libraries                                                                                      total expected diversity 2 â«» 1010 peptides added                                                                                      plate isolate binding phage. selections carried                                                                                      bacterial proteins yielded phage particles bound
                                                                                     specifically protein irrele-
                                                                                     vant control proteins. Replicative intermediate DNA                                                                                      phage sequenced determine amino acid se-
                                                                                     quences peptides displayed phage. Correlations
   FIG 1. Expression vectors.   Peptide intracellular expression vec-              drawn amino acid sequences strong
tor pKBU-Tet/GST based Clontech pPROTet.E332-lacZ                          binding target  assessed relative phage affinity exper-
vector. SalI NheI sites introduced cassette,              iments [data shown]), representative peptides gene GST 5â¬˜ hinge region inserted HindIII                chosen synthesis. synthetic peptides character-
PstI sites. Subsequently, peptides cloned SalI NheI
sites. (B) Protein intracellular expression vector pKBU-Pro-Lar                   ized relative binding cross-competition (data based Clontech pPROLar.A222 vector. NdeI, BspHI, SmaI                     shown) confirm binding specificity. Peptides identified
sites introduced cassette cloned KpnI PacI sites.             strong, specific binders expressed intracellularly
Subsequently, target genes cloned NdeI                  GST fusions. Sequences peptides described BspHI SmaI sites. RBS, ribosome binding site.
                                                                                     report shown Table 1.
                                                                                        Intracellular expression peptide-GST fusions inhibits
                                                                                     bacterial growth. Oligonucleotide cassettes designed 
diluted 1:100 (10 â?®l 1 ml) 96 block, fresh selective medium
containing inducer peptide expression, anhydrotetracyline (100 ng/ml),                                                                                      coding amino acid sequences protein-specific pep- inducers protein expression, L-(â«¹)-arabinose (0.2  ) isopro-      tides isolated phage display. random control peptide
pyl-1-thio-â?¤-D-galactopyranoside (1 mM). Induced cultures grown 22Â°C,        designed general amino acid composi- optical densities read 48 h.                                          tion growth-inhibitory peptides different primary
   Cultures diluted 1:1,000 3 h induction; plated 2â«» YT
                                                                                     sequence. Oligonucleotide cassettes cloned ex-
solid medium containing chloramphenicol, spectinomycin, kanamycin, 
ducers; grown overnight 37Â°C.                                                 pression vector pKBU-Tet/GST. Cells containing 
   Western blotting. Equal volumes overnight cultures cells carrying pKBU-     struct grown overnight 37Â°C diluted 1:100 Tet-peptide-GST constructs diluted fresh selective medium containing       fresh liquid media inducer anhydrotetra-
inducer grown 37Â°C. 0, 1, 2, 3, 4 h, optical densities measured   cycline. cultures grown 22Â°C, optical samples taken. Cell samples resuspended concentration 1
absorbance unit 600 nm ml SDS sample buffer (3  sodium dodecyl
                                                                                     densities tracked 48 hours. Expression target-
sulfate, 1 mM dithiothreitol, 10   glycerol, 63 mM Tris-HCl [pH 6.8]), boiled    specific peptide-GST fusion inhibit cell growth (Fig. 2).
2 min, applied 4 20  gradient polyacrylamide gels. resolved            expression protein-specific peptide-GST fusions 
 2878      BENSON ET AL.                                                                                       ANTIMICROB. AGENTS CHEMOTHER.


                                                                           LpxA DnaN subcloned expression vector
                                                                           pKBU/ProLar. new construct transformed cells
                                                                           containing peptide-GST fusion constructs 920-
                                                                           GST 1337-GST. Plasmid DNAs isolated transfor-
                                                                           mants sequenced, confirmed presence                                                                            constructs  peptide-GST fusion plasmid target plas-
                                                                           mid) cell strain generated.
                                                                              peptide-GST fusion target protein 
                                                                           duced, individually simultaneously, growth                                                                            liquid culture 22Â°C tracked 48 h. Induction LpxA
                                                                           little effect cell growth, induction DnaN
                                                                           slight inhibitory effect cell growth. Overexpres-
  FIG. 2. Intracellular peptide expression. presence inducer anhydrotetracycline, peptide specific essential cellular    sion peptide fusions 920-GST 1337-GST resulted
protein produced inside cell N-terminal fusion GST.        significant growth inhibition.  cells expressing
Specific peptide binding target protein inhibits essential      target protein peptide fusion, peptide-dependent
function causes growth inhibition.
                                                                           growth inhibition fully partially relieved,                                                                            target-specific manner (Fig. 4). experiments sulted various degrees inhibition; representative data           repeated times similar results. effects
peptides inhibitory effects shown Fig. 3.             seen plated cultures (Fig. 5). Plate B shows growth included peptides 729 (RpoD), 1337 (DnaN), 72                        inhibition cells induction peptides. Plate D shows
(ProRS), 1706 (Era), 920 (LpxA), 1396 (GyrA), 1330                     induction peptides targets reveals specificity (SecA). random peptide did inhibit growth,                 rescue: overexpression LpxA rescues growth inhibition
shown Fig. 3. Western blotting cells soon             caused cognate peptide 920 caused induction peptide expression using anti-GST antibodies                  DnaN cognate peptide 1337. Similarly, overexpression showed fusions expressed               DnaN specifically rescues growth inhibition caused cog-
correlation growth inhibition level peptide                 nate peptide 1337 caused peptide 920. (Plate expression (data shown).                                               shows uninduced cells, plate C shows induction target
  Expression specific target protein rescues peptide-depen-             . Overexpression SecA rescued growth inhibition
dent growth inhibition. DNAs encoding target proteins                  caused SecA cognate peptide 1330;  overexpres-




  FIG. 3. Intracellular peptide expression inhibits cell growth. Cells plasmid carrying inducible target-specific peptide fused GST grown absence (striped bars) presence (solid bars) inducer; absorbance 600 nm read 44 48 h induction.
Data expressed relative uninduced control given peptide, absorbance uninduced control 600 nm representing
100 . Peptide identification numbers given data set; peptide target given data set. peptide RND noninhibitory peptide, using amino acids generally like inhibitory peptides randomized primary sequence. Data shown representative experiments.
 VOL. 47, 2003                                                               PROTEIN KNOCKOUT PEPTIDE EXPRESSION                        2879




  FIG. 4. Specific rescue peptide-dependent growth inhibition. Dotted bars, protein (LpxA DnaN) induction; striped bars, peptide (920 1337) induction; cross-hatched bars: coinduction. Peptide 920 originally selected vitro LpxA; peptide 1337 selected DnaN. absorbance cultures 600 nm read 48 h induction protein peptide liquid medium. Data expressed relative obtained uninduced control cultures grown parallel; error bars standard deviations.


                                                                          sion RpoD did rescue growth inhibition caused RpoD
                                                                          cognate peptide 729 (data shown).

                                                                                                    DISCUSSION
                                                                             demonstrated protein knockout method iso-
                                                                          lating peptides phage display libraries specifically
                                                                          directed essential bacterial proteins showing                                                                           intracellular expression peptides inhibits bacterial
                                                                          growth. contrast, intracellular expression peptides                                                                           amino acid composition scrambled sequence
                                                                          did cause inhibition growth. correlation
                                                                          growth inhibition level expression tested
                                                                          peptide-GST fusions.  growth-inhibitory effects
                                                                          seen mere protein overexpression                                                                           amino acid composition fusions  instead, require                                                                           specific amino acid sequence peptides identified                                                                           phage display. Furthermore, overexpression target protein
                                                                          relieved inhibition caused corresponding peptide                                                                           different peptide proteins tested (DnaN,
                                                                          LpxA, SecA). findings support hypothesis                                                                           intracellular expression peptides directed essential bac-
                                                                          terial targets interfere cell growth. approach
  FIG. 5. Specific rescue peptide-dependent growth inhibition.         successful proteins known essential predict
Cultures plated selective medium containing appropriate        successfully identify essential proteins unknown
ducers 3 h induction protein peptide liquid medium     function encoded microbial genomes. grown 16 h 37Â°C.   induction; (B) peptide               surprising peptides selected bind specific
induction  (C) protein induction  (D) peptide protein
induction. quadrant labeled protein peptide,
                                                                          protein inhibit function protein intracellu-
respectively, expression induced. Peptide 920 selected    larly. phage display process selects peptides bind
LpxA; peptide 1337 selected DnaN.                                  active functional sites random sites protein
 2880     BENSON ET AL.                                                                                          ANTIMICROB. AGENTS CHEMOTHER.


surfaces (21, 26). phenomenon completely          genomics targets. Knowledge function lacking understood, known active sites possess physicochem-         open reading frames (ORFs) discovered genome sequenc-
ical properties deep, flexible clefts evolved     ing, 20  ORFs genome studied
bind ligands (28, 48). addition, peptide binding           bacterium E. coli known function (43). ad-
clefts energetically favorable (11). Accordingly, activity      vantage method direct demonstration essenti- enzymes inhibited peptides vitro,        ality protein level level antimicrobial
inhibition quite specific. Enzymes inhibited way         drug act. essentiality protein demonstrated,
clude prolyl- tyrosyl-tRNA synthetases (24), â?¤-glucosidase         method used genetic tool acquire
(24), hexokinase (24), glycogen phosphorylase (24), alcohol          functional information. example, extragenic suppressors dehydrogenase (24), enzyme phosphotransferase sys-            peptide-induced death isolated. Function tem (31), rRNA methyltransferase (19), human immunodefi-               addressed use transcription profiling proteom-
ciency virus HIV integrase (37), membrane dipeptidase (38),            ics approaches known protein question NADPH-dependent oxidase (12), protein phosphatase (49),              essential.
Src kinase (34), urease (23), diphosphocytidine methyl-               Peptides shown knock function specific protein
erythritol synthase   Jacobi, , H. Baum, T. Nakano, R. R.          intracellularly used tools drug screening (6).
Annand, S. Anderson, J. Breunig, S. Bowes, P. Goldenblatt,             example, peptide competed target
S. S. Ashraf, H. GrÃ¸n, P. Hamilton, D. J. Christensen, H.          protein small molecules suitable drug development. Loferer, Program Abstr. 41st Intersci. Conf. Antimicrob.               instance, peptide specifically binds E. coli Dxr Agents Chemother., abstr. 2124, 2001). Biologically relevant           used high-throughput â€œsurrogate ligandâ€? displacement
associations proteins peptides              assay: 32,000 compounds diverse historical library seen crystal structures. Peptides selected phage display      screened way, 30 compounds identified DM2 oncoprotein resembled portion p53 sub-              inhibited Dxr activity 50  inhibitory concentrations 
strate seen crystal structure bind DM2 binding        der 20 â?®M (20). kind peptide competition assay pocket (3, 4, 27). peptide selected phage display         used format high-throughput screens diffi- target inhibited targetâ€™s biochemical ac-        cult assay targets, DnaN, sliding-clamp subunit
tivity targetâ€™s active site cocrystal   DNA polymerase III (D. J. Christensen, E. B. Gottlin, R. E.
(P. Bernasconi, Abstr. HTS Appl. Agribusiness, SBS North               Benson, P. T. Hamilton, Program Abstr. 41st Intersci.
Carolina Regional Meeting, 2002). examples make clear            Conf. Antimicrob. Agents Chemother., abstr. 2131, 2001.) peptides bind active sites inhibit function         format used discover drugs directed vitro inhibit function intracellularly.            targets unknown function. purpose, peptide     difficult draw conclusions intracellular       target validated drug discovery peptide expression does lead growth inhibition.              results peptide overexpression cell growth.
obtained result peptides isolated proteins
dihydrofolate reductase (DHFR) deoxyxylulose reductoi-                                       ACKNOWLEDGMENTS
somerase (Dxr). Mutants defective folA (encoding DHFR)                thank Erin Anderson, Kellie Duke, E. Sturgis Payne slow growing rich media (22), mutants defective          excellent technical assistance.
yaeM (encoding Dxr) viable rich media unless spe-             work supported National Institutes Health
cifically supplemented methylerythritol (45).             grant 5 R43 AI 46036-02.
cases, peptides isolated phage display competed                                          REFERENCES protein antimicrobial drugs specific pro-          1. Blum, J. H., S. L. Dove,  Hochschild, J. J. Mekalanos. 2000. Isolation
tein; additionally, Dxr-specific peptides inhibited             peptide aptamers inhibit intracellular processes. Proc. Natl. Acad. Sci. biochemical activity Dxr (reference 20 data                 USA 97:2241â€“2246.
                                                                        2. Bohman, K., L.  Isaksson. 1980. temperature-sensitive mutant shown). growth inhibition intracellular expression              prolinyl-tRNA ligase Escherichia coli K-12. Mol. Gen. Genet. 177:603â€“ peptides seen, number possible                  605.
explanations. include nonessentiality protein,             3. Bottger, , V. Bottger, C. Garcia-Echeverria, P. Chene, H. K. Hochkeppel,
                                                                           W. Sampson, K. Ang, S. F. Howard, S. M. Picksley, D. P. Lane. 1997.
binding peptide site relevant essential             Molecular characterization hdm2-p53 interaction. J. Mol. Biol. 269:
function protein, protection protein peptide            744â€“756.
                                                                        4. Bottger, V.,  Bottger, S. F. Howard, S. M. Picksley, P. Chene, C. Garcia-
inhibition substrate assembly multienzyme com-               Echeverria, H. K. Hochkeppel, D. P. Lane. 1996. Identification novel
plexes, insufficient expression peptide. Furthermore,           mdm2 binding peptides phage display. Oncogene 13:2141â€“2147. intracellular peptide-protein complexes efficiently         5. Caponigro, G., M. R. Abedi,  P. Hurlburt,  Maxfield, W. Judd, 
                                                                           Kamb. 1998. Transdominant genetic analysis growth control pathway.
formed, low level residual activity unbound protein              Proc. Natl. Acad. Sci. USA 95:7508â€“7513. suffice growth. factors cause           6. Christensen, D. J., E. B. Gottlin, R. E. Benson, P. T. Hamilton. 2001.
incomplete growth inhibition, seen present study,            Phage display target-based antibacterial drug discovery. Drug Discovery
                                                                           Today 6:721â€“727.
example, SecA peptide. sufficient numbers pep-           7. Cohen, B. , P. Colas, R. Brent. 1998. artificial cell-cycle inhibitor
tides tested, ambiguity resolved given            isolated combinatorial library. Proc. Natl. Acad. Sci. USA 95:14272â€“
                                                                           14277.
protein. technique useful clear growth         8. Cohen, M. L. 2000. Changing patterns infectious disease. Nature 406:762â€“
inhibition phenotype observed minimal number                  767.
peptides protein-specific rescue demonstrated.              9. Colas, P., B. Cohen, T. Jessen,  Grishina, J. McCoy, R. Brent. 1996.
                                                                           Genetic selection peptide aptamers recognize inhibit cyclin-
   protein knockout method does depend prior                    dependent kinase 2. Nature 380:548â€“550.
knowledge function suited use             10. Coleman, K., M. Athalye,  Clancey, M. Davison, D. J. Payne, C. R. Perry,
 VOL. 47, 2003                                                                               PROTEIN KNOCKOUT PEPTIDE EXPRESSION                                      2881

       Chopra. 1994. Bacterial resistance mechanisms therapeutic targets.        31. Mukhija, S., B. Erni. 1997. Phage display selection peptides       J. Antimicrob. Chemother. 33:1091â€“1116.                                                 enzyme phosphoenolpyruvate-sugar phosphotransferase 11.   Conte, L. L., C. Chothia, J. Janin. 1999. atomic structure protein-          (PTS). Mol. Microbiol. 25:1159â€“1166.
      protein recognition sites. J. Mol. Biol. 285:2177â€“2198.                             32. Mushegian,  R., E. V. Koonin. 1996. minimal gene set cellular
12.   DeLeo, F. R., L. Yu, J. B. Burritt, L. R. Loetterle, C. W. Bond,  J. Jesaitis,        life derived comparison complete bacterial genomes. Proc. Natl. Acad.
      M. T. Quinn. 1995. Mapping sites interaction p47-phox fla-                Sci. USA 93:10268â€“10273.
      vocytochrome b random-sequence peptide phage display libraries. Proc.          33. Nakamura, Y. 1978. RNA polymerase mutant altered sigma factor       Natl. Acad. Sci. USA 192:7110â€“7114.                                                     Escherichia coli. Mol. Gen. Genet. 165:1â€“6.
13.   Fabbrizio, E., L. Le Cam, J. Polanowska, M. Kaczorek, N. Lamb, R. Brent,            34. Nishi, T., R. J. Budde, J. S. McMurray, N. U. Obeyesekere, N. Safdar, V. 
      C. Sardet. 1999. Inhibition mammalian cell proliferation geneti-              Levin., H. Saya. 1996. Tight-binding inhibitory sequences       cally selected peptide aptamers functionally antagonize E2F activity.              pp60(c-src) identified using random 15-amino-acid peptide library. FEBS
      Oncogene 18:4357â€“4363.                                                                  Lett. 399:237â€“240.
14.   Fauci,  2001. Infectious diseases: considerations 21st century. Clin.     35. Oliver, D. B., J. Beckwith. 1982. Regulation membrane component
      Infect. Dis. 32:675â€“685.                                                                required protein secretion Escherichia coli. Cell 30:311â€“319.
15.   Fraser, C. M., J.  Eisen, S. L. Salzberg. 2000. Microbial genome              36. Oram, M., R. Kuroda, L. M. Fisher. 1992. Escherichia coli DNA gyrase:
      sequencing. Nature 406:799â€“803.                                                         genetic analysis gyrA gyrB mutations responsible thermosensitive
16.   Galloway, S. M., C. R. Raetz. 1990. mutant Escherichia coli defec-             enzyme activity. FEBS Lett. 312:61â€“65.
      tive step endotoxin biosynthesis. J. Biol. Chem. 265:6394â€“6402.     37. Puras Lutzke, R. , N.  Eppens, P.  Weber, R.  Houghten, R. H.
17.   Geyer, C. R., R. Brent. 2000. Selection genetic agents random               Plasterk. 1995. Identification hexapeptide inhibitor human im-
      peptide aptamer expression libraries. Methods Enzymol. 328:171â€“208.                     munodeficiency virus integrase protein using combinatorial chemical
18.   Geyer, C. R.,  Colman-Lerner, R. Brent. 1999. â€œMutagenesisâ€?                    library. Proc. Natl. Acad. Sci. USA 92:11456â€“11460.
      peptide aptamers identifies genetic network members pathway connec-             38. Rajotte, D., E. Ruoslahti. 1999. Membrane dipeptidase receptor
      tions. Proc. Natl. Acad. Sci. USA 96:8567â€“8572.                                         lung-targeting peptide identified vivo phage display. J. Biol. Chem.
19.   Giannattasio, R. B., B. Weisblum. 2000. Modulation erm methyl-                   274:11593â€“11598.
      transferase activity peptides derived phage display. Antimicrob.            39. Rosamond, J.,  Allsop. 2000. Harnessing power genome       Agents Chemother. 44:1961â€“1963.                                                         search new antibiotics. Science 287:1973â€“1976.
20.   Gottlin, E. B., R. E. Benson, S. Conary, B. Antonio, K. Duke, E. S. Payne,          40. Sakakibara, Y., T. Mizukami. 1980. temperature-sensitive Escherichia
      S.  Ashraf, D. J. Christensen. 2003. High throughput screen                   coli mutant defective DNA replication: dnaN, new gene adjacent       inhibitors 1-deoxy-d-xylulose 5-phosphate reductoisomerase surrogate              dnaA gene. Mol. Gen. Genet. 178:541â€“553.
      ligand competition. J. Biomol. Screen. 8:332â€“339.                                   41. Sandrock, T., M. Poritz, M. Kim, M. J. Feldhaus, B. Roth, G. Caponigro,
21.   GrÃ¸n, H., R. Hyde-DeRuyscher. 2000. Peptides tools drug discov-                Kamb. 2002. Expression levels transdominant peptides pro-
      ery. Curr. Opin. Drug Discovery Dev. 3:636â€“645.                                         teins Saccharomyces cerevisiae. Yeast 19:1â€“7.
22.   Herrington M. B., N. T. Chirwa. 1999. Growth properties folA null          42. Schmid, M. B. 1998. Novel approaches discovery antimicrobial
      mutant Escherichia coli K12.  J. Microbiol. 45:191â€“200.                          agents. Curr. Opin. Chem. Biol. 2:529â€“534.
23.   Houimel, M., J. P. Mach,  Corthesy-Theulaz, B. Corthesy,  Fisch.            43. Serres, M. H., S. Gopal, L.  Nahum, P. Liang, T. Gaasterland, M.
      1999. New inhibitors Helicobacter pylori urease holoenzyme selected             Riley. 2001. functional update Escherichia coli K-12 genome. Ge-
      phage-displayed peptide libraries. Eur. J. Biochem. 262:774â€“780.                        nome Biol. 2 [Online.] http://genomebiology.com/2001/2/9/research/0035.
24.   Hyde-DeRuyscher, R., L. Paige, D. Christensen, N. Hyde-DeRuyscher,                44. Sparks,  B., N. B. Adey, S. Cwirla, B. K. Kay. 1996. Screening phage-
      Lim,  Fredericks, J. Kranz, P. Gallant, J. S. Zhang, S. Rocklage, D.                  displayed random peptide libraries, p. 227â€“253. B. K. Kay, J. Winter,       Fowlkes, P. Wendler, P. Hamilton. 2000. Detection small-molecule                 J. McCafferty (ed.), Phage display peptides proteins, laboratory
      enzyme inhibitors peptides isolated phage-displayed combinato-                manual. Academic Press, , San Diego, Calif.
      rial peptide libraries. Chem. Biol. 7:17â€“25.                                        45. Takahashi, S., T. Kuzuyama, H. Watanabe, H. Seto. 1998. 1-deoxy-
25.   Itaya, M. 1995. estimation minimal genome size required life.                 D-xylulose 5-phosphate reductoisomerase catalyzing formation 2-C-
      FEBS Lett. 362:257â€“260.                                                                 methyl-D-erythritol 4-phosphate alternative nonmevalonate pathway
26.   Kay, B. K., P. T. Hamilton. 2001. Identification enzyme inhibitors               terpenoid biosynthesis. Proc. Natl. Acad. Sci. USA 95:9879â€“9884.
      phage-displayed combinatorial peptide libraries. Comb. Chem. High              46. Tao, J., P. Wendler, G. Connelly,  Lim, J. Zhang, M. King, T. Li, J. 
      Throughput Screen. 4:535â€“543.                                                           Silverman, P. R. Schimmel, F. P. Tally. 2000. Drug target validation:
27.   Kussie, P. H., S. Gorina, V. Marechal, B. Elenbaas, J. Moreau,  J. Levine,            lethal infection blocked inducible peptide. Proc. Natl. Acad. Sci. USA
      N. P. Pavletich. 1996. Structure MDM2 oncoprotein bound               97:783â€“786.
      p53 tumor suppressor transactivation domain. Science 274:948â€“953.                   47. Walker, J. R., J. R. Roth, E. Altman. 2001. vivo study novel
28.   Laskowski, R. , N. M. Luscombe, M. B. Swindells, J. M. Thornton.                  bioactive peptides inhibit growth Escherichia coli. J. Pept. Res.
      1996. Protein clefts molecular recognition function. Protein Sci.                58:380â€“388.
      5:2438â€“2452.                                        